Brett Fortune, MD
Hepatology · Miami, FLNPI 1720121585
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 31.5% of the total. 2025 is the largest year on record at $56,594, 2.1 times the $27,538 reported in 2019.
Across 152 payments — averaging $970.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$46K
- Novo Nordisk$35K
- Madrigal Pharmaceuticals$20K
- BD$9K
- Bard Peripheral Vascular, Inc.$9K
- Dova Pharmaceuticals$7K
- plus $21K from 11 others
Across 44 payments — averaging $4992.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$96K
- AstraZeneca$92K
- Grifols Therapeutics LLC$14K
- Dova Pharmaceuticals$13K
- Mallinckrodt Enterprises LLC$5K
What the payments were for
- Consulting fees$57,72339%
- Speaking & faculty fees$70,37448%
- Travel & lodging$12,1718%
- Food & beverage$7,2265%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 63 | $46,450 |
| Novo Nordisk | 15 | $34,678 |
| Madrigal Pharmaceuticals | 18 | $20,457 |
| BD | 8 | $9,289 |
| Bard Peripheral Vascular, Inc. | 4 | $8,906 |
| Dova Pharmaceuticals | 5 | $6,889 |
| Wilson Cook Medical Incorporated | 3 | $6,463 |
| Gilead | 12 | $4,944 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $4,688 |
| Bausch Health US, LLC | 3 | $3,654 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $245 |
| Mirum Pharmaceuticals, Inc. | 3 | $196 |
| Mallinckrodt Hospital Products Inc. | 3 | $192 |
| Intercept Pharmaceuticals, Inc. | 2 | $144 |
| Cook Medical LLC | 1 | $128 |
| Boston Scientific | 1 | $125 |
| Kamada Ltd. | 1 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$26,553
- VIATORR Endoprosthesis$20,470
- VIATORR TIPS Endoprosthesis$20,302
- REZDIFFRA$20,112
- DOPTELET$6,750
- EchoTip$5,913
- XIFAXAN$4,482
- Livdelzi$3,954
- GORE VIATORR TIPS Endoprosthesis$1,666
- GORE VIATORR TIPS Endoprosthesis with Controlled Expansion$1,650
- CARDIOFORM Septal Occluder$612
- Product in Development$590
- Cook Medical Endoscopic Ultrasound$550
- VIATORR TIPS Endoprosthesis w/ Controlled Expansion$348
- Epclusa$284
- RESMETIROM$166
- TERLIVAZ$142
- VIATORR TIPS Endoprosthesis w/$138
- Liverty$131
- ECHOTIP INSIGHT$128
How this compares
Too few hepatology providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tenofovir Disoproxil Fumarate | 22 | $5,314 |
| Ursodiol | 35 | $2,419 |
| Spironolactone | 15 | $173 |
| Carvedilol | 26 | $74 |
Paid to pharmacies, not to this prescriber.
Other hepatology in Miami
- Cynthia LevyMiami$88K
- Flavia MendesMiami$6K
- Leopoldo ArosemenaMiami$4K
- Eugene SchiffMiami$405
- Patricia JonesMiami$229
- Mina ShakerMiami$105
- Lennox JeffersMiami$0
- Shady GuirguisOrlando$100K
- Miguel MalespinTampa$64K
- Arvind Rangarajan MuraliOrlando$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.